159 related articles for article (PubMed ID: 32250627)
1. BIreactive: A Machine-Learning Model to Estimate Covalent Warhead Reactivity.
Palazzesi F; Hermann MR; Grundl MA; Pautsch A; Seeliger D; Tautermann CS; Weber A
J Chem Inf Model; 2020 Jun; 60(6):2915-2923. PubMed ID: 32250627
[TBL] [Abstract][Full Text] [Related]
2. A Fast Ab Initio Predictor Tool for Covalent Reactivity Estimation of Acrylamides.
Palazzesi F; Grundl MA; Pautsch A; Weber A; Tautermann CS
J Chem Inf Model; 2019 Aug; 59(8):3565-3571. PubMed ID: 31246457
[TBL] [Abstract][Full Text] [Related]
3. BIreactive: Expanding the Scope of Reactivity Predictions to Propynamides.
Hermann MR; Tautermann CS; Sieger P; Grundl MA; Weber A
Pharmaceuticals (Basel); 2023 Jan; 16(1):. PubMed ID: 36678612
[TBL] [Abstract][Full Text] [Related]
4. Expanding the Armory: Predicting and Tuning Covalent Warhead Reactivity.
Lonsdale R; Burgess J; Colclough N; Davies NL; Lenz EM; Orton AL; Ward RA
J Chem Inf Model; 2017 Dec; 57(12):3124-3137. PubMed ID: 29131621
[TBL] [Abstract][Full Text] [Related]
5. The expanding repertoire of covalent warheads for drug discovery.
Mehta NV; Degani MS
Drug Discov Today; 2023 Dec; 28(12):103799. PubMed ID: 37839776
[TBL] [Abstract][Full Text] [Related]
6. Characterising covalent warhead reactivity.
Martin JS; MacKenzie CJ; Fletcher D; Gilbert IH
Bioorg Med Chem; 2019 May; 27(10):2066-2074. PubMed ID: 30975501
[TBL] [Abstract][Full Text] [Related]
7. A study of the reactivity of S
Mukherjee H; Debreczeni J; Breed J; Tentarelli S; Aquila B; Dowling JE; Whitty A; Grimster NP
Org Biomol Chem; 2017 Nov; 15(45):9685-9695. PubMed ID: 29119993
[TBL] [Abstract][Full Text] [Related]
8. Electrophilic warheads in covalent drug discovery: an overview.
Péczka N; Orgován Z; Ábrányi-Balogh P; Keserű GM
Expert Opin Drug Discov; 2022 Apr; 17(4):413-422. PubMed ID: 35129005
[TBL] [Abstract][Full Text] [Related]
9. Integrated Covalent Drug Design Workflow Using Site Identification by Ligand Competitive Saturation.
Yu W; Weber DJ; MacKerell AD
J Chem Theory Comput; 2023 May; 19(10):3007-3021. PubMed ID: 37115781
[TBL] [Abstract][Full Text] [Related]
10. Binding Mode Prediction and Virtual Screening Applications by Covalent Docking.
Scarpino A; Ferenczy GG; Keserű GM
Methods Mol Biol; 2021; 2266():73-88. PubMed ID: 33759121
[TBL] [Abstract][Full Text] [Related]
11. Reactivities of acrylamide warheads toward cysteine targets: a QM/ML approach to covalent inhibitor design.
Danilack AD; Dickson CJ; Soylu C; Fortunato M; Rodde S; Munkler H; Hornak V; Duca JS
J Comput Aided Mol Des; 2024 May; 38(1):21. PubMed ID: 38693331
[TBL] [Abstract][Full Text] [Related]
12. Covalent inhibitor reactivity prediction by the electrophilicity index-in and out of scope.
Hermann MR; Pautsch A; Grundl MA; Weber A; Tautermann CS
J Comput Aided Mol Des; 2021 Apr; 35(4):531-539. PubMed ID: 33015740
[TBL] [Abstract][Full Text] [Related]
13. Development and application of novel electrophilic warheads in target identification and drug discovery.
Liu Y; Lv S; Peng L; Xie C; Gao L; Sun H; Lin L; Ding K; Li Z
Biochem Pharmacol; 2021 Aug; 190():114636. PubMed ID: 34062128
[TBL] [Abstract][Full Text] [Related]
14. Covalent peptides and proteins for therapeutics.
Berdan VY; Klauser PC; Wang L
Bioorg Med Chem; 2021 Jan; 29():115896. PubMed ID: 33285408
[TBL] [Abstract][Full Text] [Related]
15. Emerging and Re-Emerging Warheads for Targeted Covalent Inhibitors: Applications in Medicinal Chemistry and Chemical Biology.
Gehringer M; Laufer SA
J Med Chem; 2019 Jun; 62(12):5673-5724. PubMed ID: 30565923
[TBL] [Abstract][Full Text] [Related]
16. Covalent Docking in Drug Discovery: Scope and Limitations.
Scarpino A; Ferenczy GG; Keserű GM
Curr Pharm Des; 2020; 26(44):5684-5699. PubMed ID: 33155894
[TBL] [Abstract][Full Text] [Related]
17. Arylfluorosulfate-Based Electrophiles for Covalent Protein Labeling: A New Addition to the Arsenal.
Martín-Gago P; Olsen CA
Angew Chem Int Ed Engl; 2019 Jan; 58(4):957-966. PubMed ID: 30024079
[TBL] [Abstract][Full Text] [Related]
18. Emerging and Re-emerging Warheads for Targeted Covalent Inhibitors: An Update.
Hillebrand L; Liang XJ; Serafim RAM; Gehringer M
J Med Chem; 2024 May; 67(10):7668-7758. PubMed ID: 38711345
[TBL] [Abstract][Full Text] [Related]
19. Comparative reactivity analysis of small-molecule thiol surrogates.
Petri L; Ábrányi-Balogh P; Varga PR; Imre T; Keserű GM
Bioorg Med Chem; 2020 Apr; 28(7):115357. PubMed ID: 32081630
[TBL] [Abstract][Full Text] [Related]
20. Quantum Descriptors for Predicting and Understanding the Structure-Activity Relationships of Michael Acceptor Warheads.
Liu R; Vázquez-Montelongo EA; Ma S; Shen J
J Chem Inf Model; 2023 Aug; 63(15):4912-4923. PubMed ID: 37463342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
